EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access

Patients’ Attitudes and Beliefs Toward Artificial Intelligence Use in Cancer Care: Cross-Sectional Survey Study

Marco Santos Teles iD, Karolina Bryl iD, Susan Chimonas iD, Atif Khan iD, Andrew S Epstein iD, Bobby Daly iD, Han Xiao iD, Jun J Mao iD

JMIR Cancer · 04.02.2026 · 12 · e81346-e81346

DOI: 10.2196/81346 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift JMIR Cancer, online erschienen am 04.02.2026. Verfasst von Marco Santos Teles und 7 weiteren Autor:innen. Beteiligte Einrichtung: Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 205 East 64th Street, New York, NY, 10022, United States, 1 646 608 8552. Hauptthemen laut MEDLINE: Artificial Intelligence, Neoplasms, Health Knowledge, Attitudes, Practice. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Artificial intelligence (AI) is being rapidly integrated into oncologic care, yet little is known about how patients perceive these applications. Understanding patient perceptions is critical to ensuring AI applications align with their needs and preferences.

Objective

This study aimed to evaluate oncology patients’ attitudes and beliefs on the use of AI across clinical touchpoints in cancer care.

Methods

We conducted a cross-sectional survey study with adult oncology patients from September to December 2024. The survey assessed patients’ comfort with AI use across 8 clinical touchpoints of cancer care (eg, screening, diagnosis, treatment) on a 5-point Likert scale (1=very uncomfortable to 5=very comfortable). Patients also rated their concerns about AI, including potential harms related to its use (eg, medical errors, privacy breaches), on a 3-point Likert scale (1=not concerned to 3=very concerned).

Results

Of 383 patients approached, 330 (86.2% response rate) participated; 184 (55.9%) were male, 162 (49.4%) were aged 65 years or older, 35 (10.8%) were Black, 40 (12.1%) were Hispanic or Latino, and 233 (72.6%) were actively receiving cancer treatment. Patients were most comfortable with AI use in cancer screening (80.2%) and supportive care applications, including exercise (78.2%), diet (74.8%), and herbs/supplements (72.4%). Patients were least comfortable with AI use to assist with diagnosis (70.4%), symptom management (67.5%), treatment planning (64.8%), and prognosis (61.5%). Nonetheless, about half (49.7%) were at least somewhat concerned with the use of AI in cancer care, most commonly about the loss of human interaction and medical errors.

Conclusions

Although the majority of oncology patients had a favorable view of AI in cancer care, nearly half had concerns about potential harms. Incorporating patient perspectives into AI development is essential for patient-centered and high-quality cancer care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceNeoplasmsHealth Knowledge, Attitudes, PracticeHumansCross-Sectional StudiesMaleFemaleMiddle AgedAgedSurveys and QuestionnairesAdult

Stichwörter der Autor:innen

artificial intelligencecancer caredigital healthpatient attitudespatient perspectives

Autor:innen und Institutionen

  • Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 205 East 64th Street, New York, NY, 10022, United States, 1 646 608 8552.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.

ORCID-Profile: Marco Santos Teles, Karolina Bryl, Susan Chimonas, Atif Khan, Andrew S Epstein, Bobby Daly, Han Xiao, Jun J Mao

Förderung

  • NCI NIH HHS

Zitieren

APA

Santos Teles, M., Bryl, K., Chimonas, S., Khan, A., Epstein, A. S., Daly, B., Xiao, H., & Mao, J. J. (2026). Patients’ Attitudes and Beliefs Toward Artificial Intelligence Use in Cancer Care: Cross-Sectional Survey Study. JMIR Cancer, 12, e81346-e81346. https://doi.org/10.2196/81346

Vancouver

Santos Teles M, Bryl K, Chimonas S, Khan A, Epstein AS, Daly B, et al. Patients’ Attitudes and Beliefs Toward Artificial Intelligence Use in Cancer Care: Cross-Sectional Survey Study. JMIR Cancer. 2026;12:e81346-e81346. doi:10.2196/81346

BibTeX
@article{SantosTeles2026,
  author = {Santos Teles, Marco and Bryl, Karolina and Chimonas, Susan and Khan, Atif and Epstein, Andrew S and Daly, Bobby and Xiao, Han and Mao, Jun J},
  title = {Patients’ Attitudes and Beliefs Toward Artificial Intelligence Use in Cancer Care: Cross-Sectional Survey Study},
  journal = {JMIR Cancer},
  year = {2026},
  volume = {12},
  pages = {e81346--e81346},
  doi = {10.2196/81346}
}
Kostenlos starten →